Intrinsic Value of S&P & Nasdaq Contact Us

PolyPid Ltd. PYPD NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • IL • USD

SharesGrow Score
56/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.50
+114.9%

Stock Statistics — PYPD

PolyPid Ltd. (PYPD) has a market capitalization of $45.04M and trades at $4.42. The 52-week range is 2.3-5.12.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.1, Earnings Per Share (EPS) of $-2.09.

The stock has a beta of 1.46, operates in the Healthcare sector.

Trading Data
Current Price$4.42
52-Week Range2.3-5.12
Volume128.67K
Avg Volume (30D)60.33K
Market Cap$45.04M
Beta (1Y)1.46
Company
IPO Date2020-06-26
Employees57
CEODikla Czaczkes Akselbrad
CountryIL
ExchangeNASDAQ Global Market
CurrencyUSD
ISINIL0011326795
CUSIPM8001Q118
Income (Latest Year)
EBITDA$-31.86M
Operating Income$-32.97M
Net Income$-34.17M
EPS$-2.09
EPS Diluted$-2.09
Shares Outstanding$16.35M
Balance Sheet (Latest Year)
Total Assets$22.31M
Current Assets$15.23M
Cash & ST Investments$12.93M
Total Liabilities$11.33M
Total Debt$2.8M
Net Debt$-3.61M
Total Equity$10.97M
Debt / Equity0.25
Valuation Ratios
P/E Ratio-2.1
P/B Ratio4.1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message